Prescription medication for weight loss.
Contains semaglutide as active ingredient.
Helps reduce appetite and cravings.
Administered via once-weekly subcutaneous injection.
Supports weight management alongside diet and exercise.
Proven to improve blood sugar levels.
Promotes sustainable weight loss over time.
Suitable for adults with obesity or overweight.
Helps lower risk of heart disease in some patients.
Clinically proven for long-term weight control.
Wegovy is a prescription, once-weekly injection containing semaglutide for chronic weight management in adults and adolescents (12+) with obesity or overweight, alongside lifestyle changes. It works by mimicking the GLP-1 hormone to regulate appetite, reduce hunger, and induce fullness. Common side effects include nausea, vomiting, diarrhea, and constipation.
Contains semaglutide as active ingredient.
Helps reduce appetite and cravings.
Administered via once-weekly subcutaneous injection.
Supports weight management alongside diet and exercise.
Proven to improve blood sugar levels.
Promotes sustainable weight loss over time.
Suitable for adults with obesity or overweight.
Helps lower risk of heart disease in some patients.
Clinically proven for long-term weight control.
Wegovy is a prescription, once-weekly injection containing semaglutide for chronic weight management in adults and adolescents (12+) with obesity or overweight, alongside lifestyle changes. It works by mimicking the GLP-1 hormone to regulate appetite, reduce hunger, and induce fullness. Common side effects include nausea, vomiting, diarrhea, and constipation.
